Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

A Novel Cancer Imaging Method Using Chemiluminescence-Mediated Sonosensitization

A Novel Cancer Diagnostic Method: Fcla Assisted Sono-Dynamic Diagnosis

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Experimental Study on Photodynamic Diagnosis of Cancer Mediated by Chemiluminescence Probe

Sonoluminescence Imaging and Its Biomedical Applications

<title>High-sensitivity imaging method of singlet oxygen and superoxide anion in photodynamic and sonodynamic actions</title>

Tumor Detection with Sonodynamic Chemiluminescence from Atx-70 and Fcla under Ultrasonic Excitation

Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH

High-sensitive imaging method of singlet oxygen and Superoxide anion in photodynamic and sonodynamic actions

Localization of tumor by chemiluminescence probe during photosensitization action.

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

A Novel Luminescent Ir(iii) Complex for Dual Mode Imaging: Synergistic Response to Hypoxia and Acidity of the Tumor Microenvironment

FCLA Chemiluminescence from Sonodynamic Action in Vitro and in Vivo

Chemiluminescence Detection from Sonodynamic Action in Vitro and in Vivo

Fcla-Enhanced Sonoluminescence Imaging In Vivo

Rattle-Structured Multifunctional Nanotheranostics for Synergetic Chemo-/Radiotherapy and Simultaneous Magnetic/Luminescent Dual-Mode Imaging

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

An Ultrasound-Activated Nanozyme Sonosensitizer for Photoacoustic Imaging-Guided Breast Cancer Sonodynamic and Starvation Combination Therapy

In vivo ultrasound-induced luminescence molecular imaging

1,2‐Dioxetane‐based Chemiluminescence Probes for Tumor Optical Molecular Imaging

Illuminating cancer with sonoafterglow